Christopher Nolan is an abnormally overrated director. His movies are incorrigibly and insufferably didactic. His palette is dour. His narrative ranges from disconnected to positively unhinged (Tenet, Paprika). I could go on.
@hcls24 Would add $INSP to the medtech tactical long group too. Think they’ll sound incrementally better at Wells and provide more on their DISE replacement data
@HotspurInvestor CEO bought 1mm shares right before their slot at conference. Ballsy. So funny that they were also talking about a “GLP1 drug delivery device patent”…?
Terrific stuff from @tseides. Selfishly I hope this is his last healthcare deep dive - my alpha will dry up if he continues to demystify the HC system to generalists.
https://t.co/CNtINkPG5C
Earnings call hold music should correspond with the company’s results. Nothing worse than chipper hold music when one is about to get kicked in the face.
Here's a funny one: $RETA is getting acquired by $BIIB, but their 10-Q suggests that $MRK will be required to by them $301m in an antitrust block.
(It's a clear drafting error, but makes it pretty clear there was a hot and heavy bidding war between Merck and Biogen!)
@Borlaug_ Earning season in a nutshell lol
The new earning season framework just dropped, you got to have the balance between "We`re back x It`s so over" to outperform.
Soon it should be included in Mauboussin`s newest paper.
New paper on happiness in America since 1979.
Just fascinating. There are like 1,000 stories to tell about American life, economics, and culture in these graphs